| 臺大學術典藏 |
2020-03-05T08:04:02Z |
A comprehensive analysis of clinical outcomes in lung cancer patients harboring a MET exon 14 skipping mutation compared to other driver mutations in an East Asian population
|
Gow C.-H.;Min-Shu Hsieh;Wu S.-G.;Shih J.-Y.; Gow C.-H.; MIN-SHU HSIEH; Wu S.-G.; Shih J.-Y. |
| 國立成功大學 |
2020 |
An Observational Study of Acquired EGFR T790M-Dependent Resistance to EGFR-TKI Treatment in Lung Adenocarcinoma Patients in Taiwan
|
Wu, S.-G.;Chiang, Chiang C.-L.;Liu, C.-Y.;Wang, C.-C.;Su, P.-L.;Hsia, T.-C.;Shih, J.-Y.;Chang, G.-C. |
| 臺大學術典藏 |
2019 |
MicroRNA in lung cancer metastasis
|
Wu S.-G.;Chang T.-H.;Liu Y.-N.;Jin-Yuan Shih; Wu S.-G.; Chang T.-H.; Liu Y.-N.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2018-09-10T15:17:15Z |
Treatment outcome of patients with isoniazid mono-resistant tuberculosis
|
Yu, C. -J.; Wang, J. -Y.; Lee, J. -J.; Chien, J. -Y.;Chen, Y. -T.;Wu, S. -G.;Lee, J. -J.;Wang, J. -Y.;Yu, C. -J.; Chien, J.-Y. and Chen, Y.-T. and Wu, S.-G. and Lee, J.-J. and Wang, J.-Y. and Yu, C.-J.; 余忠仁;吳尚俊;王振源;簡榮彥; Chien, J. -Y.; Chong-Jen Yu; JANN-YUAN WANG; Chen, Y. -T.; Wu, S. -G.; JUNG-YIEN CHIEN |
| 臺大學術典藏 |
2018-09-10T09:13:23Z |
RNA is favourable for analysing EGFR mutations in malignant pleural effusion of lung cancer
|
Tsai, T.-H. and Su, K.-Y. and Wu, S.-G. and Chang, Y.-L. and Luo, S.-C. and Jane, I.-S. and Yu, C.-J. and Yue, S.-L. and Shih, J.-Y. and Yang, P.-C.; Tsai, T-H.;Su, K-Y.;Wu, S-G.;Chang, Y-L.;Luo, S-C.;Jan, I-S.;Yu, C-J.;Yu, S-L.;Shih, J-Y.;Yang, P-C.; 俞松良 ;詹一秀 ;張逸良 ;楊泮池 ;余忠仁 ;吳尚俊 ;蔡子修 ;施金元; Tsai, T-H.; YIH-LEONG CHANG; Tsai, T-H.; Chong-Jen Yu; Su, K-Y.; Wu, S-G.; Wu, S-G.; KANG-YI SU; JIN-YUAN SHIH; Chang, Y-L.; Luo, S-C.; Luo, S-C.; Jan, I-S.; Jan, I-S.; Yu, C-J.; Yu, S-L.; Shih, J-Y.; Shih, J-Y.; Yang, P-C.; 楊泮池 |
| 臺大學術典藏 |
2018-09-10T08:28:53Z |
Including total EGFR staining in scoring improves EGFR mutations detection by mutation-specific antibodies and EGFR TKIs response prediction
|
Wu, S.-G.;Chang, Y.-L.;Lin, J.-W.;Wu, C.-T.;Chen, H.-Y.;Tsai, M.-F.;Lee, Y.-C.;Yu, C.-J.;Shih, J.-Y.; CHEN-TU WU; YIH-LEONG CHANG; Chong-Jen Yu; JIN-YUAN SHIH |
| 臺大學術典藏 |
2018-09-10T07:05:53Z |
Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response
|
Wu, J.-Y.; Wu, S.-G.; Yang, C.-H.; Gow, C.-H.; Chang, Y.-L.; Yu, C.-J.; Shin, J.-Y.; Yang, P.-C.; YIH-LEONG CHANG; CHONG-JEN YU; PAN-CHYR YANG |
| 臺大學術典藏 |
2017 |
Lung adenocarcinoma patients of young age have lower EGFR mutation rate and poorer efficacy of EGFR tyrosine kinase inhibitors
|
Wu S.-G.;Yih-Leong Chang;Yu C.-J.;Yang P.-C.;Shih J.-Y.; Wu S.-G.; YIH-LEONG CHANG; Yu C.-J.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2017 |
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-sensitive Exon 19 Insertion and Exon 20 Insertion in Patients With Advanced Non–Small-cell Lung Cancer
|
Lin Y.-T.;Liu Y.-N.;Wu S.-G.;Yang J.C.-H.;Jin-Yuan Shih; Lin Y.-T.; Liu Y.-N.; Wu S.-G.; Yang J.C.-H.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2017 |
A comprehensive analysis of clinical outcomes in lung cancer patients harboring a MET exon 14 skipping mutation compared to other driver mutations in an East Asian population
|
Gow C.-H.;Hsieh M.-S.;Wu S.-G.;Jin-Yuan Shih; Gow C.-H.; Hsieh M.-S.; Wu S.-G.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2016 |
Efficacy of pemetrexed-based chemotherapy in patients with ROS1 fusion-positive lung adenocarcinoma compared with in patients harboring other driver mutations in East Asian populations
|
Chen Y.-F.; Hsieh M.-S.; Wu S.-G.; YIH-LEONG CHANG; Yu C.-J.; Yang J.C.-H.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2016 |
The role of PIK3CA mutations among lung adenocarcinoma patients with primary and acquired resistance to EGFR tyrosine kinase inhibition
|
Wu S.-G.; Chang Y.-L.; Yu C.-J.; Yang P.-C.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2016 |
Association of BIM deletion polymorphism with intrinsic resistance to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma
|
Wu S.-G.;Liu Y.-N.;Yu C.-J.;Yang P.-C.;Jin-Yuan Shih; Wu S.-G.; Liu Y.-N.; Yu C.-J.; Yang P.-C.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2016 |
The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients
|
Yu C.-J.; Yang P.-C.; Yang J.C.-H.; Wen Y.-F.; JIN-YUAN SHIH; Chang Y.-L.; Tsai M.-F.; Wu S-G.;Liu Y.-N.;Tsai M.-F.;Chang Y.-L.;Yu C.-J.;Yang P.-C.;Yang J.C.-H.;Wen Y.-F.;Jin-Yuan Shih; Wu S-G.; Liu Y.-N. |
| 國立臺灣大學 |
2015 |
Treatment outcome of patients with isoniazid mono-resistant tuberculosis
|
Chien, J. -Y.; Chen, Y. -T.; Wu, S. -G.; Lee, J. -J.; Wang, J. -Y.; Yu, C. -J.; 余忠仁; 吳尚俊; 王振源; 簡榮彥 |
| 臺大學術典藏 |
2015 |
Treatment outcome of patients with isoniazid mono-resistant tuberculosis
|
Wu S.-G.; Chen Y.-T.; Chien J.-Y.; Lee J.-J.; JANN-YUAN WANG; Yu C.-J. |
| 臺大學術典藏 |
2015 |
Clinical and prognostic implications of RET rearrangements in metastatic lung adenocarcinoma patients with malignant pleural effusion
|
Tsai T.-H.; Wu S.-G.; Hsieh M.-S.; Yu C.-J.; Yang J.C.H.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2014 |
Development of renal cysts after crizotinib treatment in advanced ALK-positive non-small-cell lung cancer
|
Yang P.-C.; JIN-YUAN SHIH; Wu S.-G.; Lin Y.-T.; Wang Y.-F.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2013 |
Phosphorylated insulin-like growth factor-1 receptor (pIGF1R) is a poor prognostic factor in brain metastases from lung adenocarcinomas
|
Wu P.-F;Huang W.-C;Chih-Hsin Yang;Lu Y.-S;Shih J.-Y;Wu S.-G;Lin C.-H;Cheng A.-L.; Wu P.-F; Huang W.-C; CHIH-HSIN YANG; Lu Y.-S; Shih J.-Y; Wu S.-G; Lin C.-H; Cheng A.-L. |
| 臺大學術典藏 |
2013 |
Frequent EGFR mutations in nonsmall cell lung cancer presenting with miliary intrapulmonary carcinomatosis
|
Wu S.-G.; Hu F.-C.; Chang Y.-L.; Lee Y.-C.; Yu C.-J.; Chang Y.-C.; Wu J.-Y.; JIN-YUAN SHIH; Yang P.-C. |
| 國立臺灣大學 |
2012 |
RNA is favourable for analysing EGFR mutations in malignant pleural effusion of lung cancer
|
Tsai, T-H.; Su, K-Y.; Wu, S-G.; Chang, Y-L.; Luo, S-C.; Jan, I-S.; Yu, C-J.; Yu, S-L.; Shih, J-Y.; Yang, P-C.; 俞松良; 詹一秀; 張逸良; 楊泮池; 余忠仁; 吳尚俊; 蔡子修; 施金元 |
| 臺大學術典藏 |
2012 |
Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma
|
Shih J.-Y.;Yang P.-C;Yu C.-J;Chih-Hsin Yang;Wei P.-F;Tsai M.-F;Wu C.-T;Chang Y.-L;Wu S.-G;Tsai T.-H; Tsai T.-H; Wu S.-G; Chang Y.-L; Wu C.-T; Tsai M.-F; Wei P.-F; CHIH-HSIN YANG; Yu C.-J; Yang P.-C; Shih J.-Y. |
| 臺大學術典藏 |
2012 |
Brain metastasis in NSCLC patients: Mechanism, diagnosis and treatment
|
Wu S.-G.;Jin-Yuan Shih; Wu S.-G.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2012 |
Clinical outcomes in non-small cell lung cancers harboring different exon 19 deletions in EGFR
|
Chung K.-P.;Wu S.-G.;Wu J.-Y.;Yang J.-H.;Yu C.-J.;Wei P.-F.;Jin-Yuan Shih;Yang P.-C.; Chung K.-P.; Wu S.-G.; Wu J.-Y.; Yang J.-H.; Yu C.-J.; Wei P.-F.; JIN-YUAN SHIH; Yang P.-C. |
| 臺大學術典藏 |
2012 |
RNA is favourable for analysing EGFR mutations in malignant pleural effusion of lung cancer
|
Chang Y.-L.; Luo S.-C.; Jane I.-S.; Yu C.-J.; Yue S.-L.; JIN-YUAN SHIH; Yang P.-C.; Wu S.-G.; Su K.-Y.; Tsai T.-H.; Tsai T.-H.;Su K.-Y.;Wu S.-G.;Chang Y.-L.;Luo S.-C.;Jane I.-S.;Yu C.-J.;Yue S.-L.;Jin-Yuan Shih;Yang P.-C. |
